Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma-Reference-Cited by-同舟云学术

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

Published:2015-09-01 Issue:3 Volume:18 Page:368-378
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Everson Richard G.,Antonios Joseph P.,Lisiero Dominique N.,Soto Horacio,Scharnweber Rudi,Garrett Matthew C.,Yong William H.,Li Ning,Li Gang,Kruse Carol A.,Liau Linda M.,Prins Robert M.

Funder

NIH/NCI

NIH/NCATS UCLA CTSI

Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research

Cancer Foundation

(R.M.P.)

UCLA MSTP

(J.P.A.)

Jonsson Comprehensive Cancer Center Foundation

(R.G.E.)

AANS Neurosurgery Research Education Fund

UCLA Jonsson Comprehensive Cancer Center

NIH

UCLA Brain Tumor Translational Resource

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/3/368/7640582/nov153.pdf

Reference21 articles.

1. Toward effective immunotherapy for the treatment of malignant brain tumors

2. Overview of cellular immunotherapy for patients with glioblastoma;Vauleon;Clin Dev Immunol,2010

3. Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization

4. Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

5. Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma;Cancer Research Communications;2024-07-01

2. CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines;2024-06-30

3. Emerging applications of hypomethylating agents in the treatment of glioblastoma (Review);Molecular and Clinical Oncology;2024-06-28

4. Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning–based cuproptosis‐related signature is identified for predicting prognosis and immunotherapy response of gliomas;CNS Neuroscience & Therapeutics;2023-07-28

5. TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker;Frontiers in Immunology;2022-10-07